✦ LIBER ✦

Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data

✍ Scribed by Sanchez, Connie; Asin, Karen E.; Artigas, Francesc

Book ID: 125841880
Publisher: Elsevier Science
Year: 2015
Tongue: English
Weight: 717 KB
Volume: 145
Category: Article
ISSN: 0163-7258
DOI: 10.1016/j.pharmthera.2014.07.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical and clinical overview of nem

Preclinical and clinical overview of nemifitide, a novel antidepressant

✍ J.P. Feighner 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Preclinical and clinical overview of INN

Preclinical and clinical overview of INN 00835, a novel pentapeptide antidepressant

✍ J.P. Feighner 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Topiramate: a review of preclinical, pha

Topiramate: a review of preclinical, pharmacokinetic, and clinical data

✍ William E. Rosenfeld 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 715 KB

Vindesine a short review of preclinical

Vindesine a short review of preclinical and first clinical data

✍ R. W. Dyke; R. L. Nelson; W. P. Brade 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 441 KB

Treatment of cognitive dysfunction in ma

Treatment of cognitive dysfunction in major depressive disorder—a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine

✍ Pehrson, Alan L.; Leiser, Steven C.; Gulinello, Maria; Dale, Elena; Li, Yan; Wal 📂 Article 📅 2015 🏛 Elsevier Science 🌐 English ⚖ 642 KB

New generation smallpox vaccines: a revi

New generation smallpox vaccines: a review of preclinical and clinical data

✍ Andrew W. Artenstein 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

## Abstract The recognition that smallpox is a potential threat agent of bioterrorism has engendered renewed interest in the development of improved vaccines against this pathogen. The purpose of this paper is to review current data regarding novel approaches to smallpox vaccines in comparison with